|
| [ На главную ] -- [ Список участников ] -- [ Правила форума ] -- [ Зарегистрироваться ] |
| On-line: |
| Клуб болельщиков "Торпедо" Владимир / / BgdgMSCjwXfcfK |
| Страницы: 1 |
|
| Автор | Сообщение |
|
Lillian Гость |
Добавлено: 12-06-2022 16:02 |
|
Sorry, you must have the wrong number simpiox gotas para q sirve TB is always treated with three or more meds to reduce emergence of drug resistance, but preclinical studies performed independently by Sequella and Pfizer show SQ109 and sutezolid to each have activity as single agents, and promising additional activity when used in combination. Privately-held Sequella added that reports estimate a $400-$500 million global peak sales market for a drug to treat MDR-TB, some 5% of TB cases worldwide. |
| Страницы: 1 |
|
| Клуб болельщиков "Торпедо" Владимир / / BgdgMSCjwXfcfK |